Abstract
Heart failure is considered to be a chronic inflammatory disease. High mobility protein B1(HMGB1) is a sensitive marker of the body, s nonspecific inflammation. Soluble advanced glycation end product receptor(sRAGE) can competitively combine with HMGB1 to reduce and inhibit inflammation, thus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
